Related references
Note: Only part of the references are listed.Cysteine-rich 61-Connective Tissue Growth Factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced Signaling Protein-2 (WISP-2) Regulates MicroRNA-10b via Hypoxia-inducible Factor-1α-TWIST Signaling Networks in Human Breast Cancer Cells
Inamul Haque et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor β Signaling Pathway
Michele Sabbah et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation
Yong-Xi Song et al.
MOLECULAR CANCER (2011)
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Joon-Il Jun et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
EMT: New signals from the invasive front
Xinhua Liang
ORAL ONCOLOGY (2011)
TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Sergey V. Novitskiy et al.
CANCER DISCOVERY (2011)
Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1/Snail Activation Aggravates Invasive Growth of Cholangiocarcinoma
Yasunori Sato et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
microRNA, Cell Cycle, and Human Breast Cancer
Zuoren Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Jie Xiang et al.
CURRENT GENOMICS (2010)
Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction
Eri Takahashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-β Switch from a Suppressor to a Promoter of Cancer Cell Proliferation
Garima Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TGF-beta 1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
Shinako Araki et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
Nongenomic Signaling Pathways of Estrogen Toxicity
Cheryl S. Watson et al.
TOXICOLOGICAL SCIENCES (2010)
CCN5: biology and pathophysiology
Joshua W. Russo et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2010)
CCN5, a secreted protein, localizes to the nucleus
Kristina C. Wiesman et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2010)
MicroRNAs and Cancer: Short RNAs Go a Long Way
Andrea Ventura et al.
CELL (2009)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2
Gopal Dhar et al.
CANCER RESEARCH (2008)
CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells
Snigdha Banerjee et al.
CANCER RESEARCH (2008)
Direct evidence for epithelial-mesenchymal transitions in breast cancer
Anthony J. Trimboli et al.
CANCER RESEARCH (2008)
The CCN family of proteins: structure-function relationships
Kenneth P. Holbourn et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α
E. H. Gort et al.
ONCOGENE (2008)
Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells
Asmaa Fritah et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: A potential mechanism for epithelial-mesenchymal-transition
Gopal Dhar et al.
CANCER LETTERS (2007)
Sex hormones and the cardiovascular system: Effects on arterial function in women
H. J. Teede
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer
Simon R. Davies et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
Lilach Weisz et al.
CANCER RESEARCH (2007)
Wild-type p53: Tumors can't stand it
Michael B. Kastan
CELL (2007)
Insulin-like growth factor-1 (IGF-1) induces WlSP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells
Kakali Dhar et al.
CANCER RESEARCH (2007)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
Src, chemoresistance and epithelial to mesenchymal transition: are they related?
Ami N. Shah et al.
ANTI-CANCER DRUGS (2007)
p53 downstream target genes and tumor suppression: a classical view in evolution
L. M. Rozan et al.
CELL DEATH AND DIFFERENTIATION (2007)
Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells
Emmanouil D. Karagiannis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens
Asmaa Fritah et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
MicroRNAs and chromosomal abnormalities in cancer cells
G. A. Calin et al.
ONCOGENE (2006)
WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Cα-mediated breast tumor cell proliferation
Krishanu Sengupta et al.
BIOCHEMISTRY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The fallacy of epithelial mesenchymal transition in neoplasia
D Tarin
CANCER RESEARCH (2005)
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
DC Radisky et al.
NATURE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Signaling from the membrane via membrane estrogen receptor-α:: Estrogens, xenoestrogens, and phytoestrogens
CS Watson et al.
STEROIDS (2005)
Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-α-positive breast tumor cells through multiple molecular cross-talks
S Banerjee et al.
MOLECULAR CANCER RESEARCH (2005)
Mechanisms of membrane estrogen receptor-α-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line
NN Bulayeva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells
C Ballaré et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor
ER Levin
MOLECULAR ENDOCRINOLOGY (2003)
WISP-2 gene in human breast cancer: Estrogen and progesterone inducible expression and regulation of tumor cell proliferation
S Banerjee et al.
NEOPLASIA (2003)
Integration of the non-genomic and genomic actions of estrogen - Membrane-initiated signaling by steroid to transcription and cell biology
A Pedram et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
WISP-2 is a secreted protein and can be a marker of estrogen exposure in MCF-7 cells
H Inadera et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Cellular functions of plasma membrane estrogen receptors
ER Levin
STEROIDS (2002)
Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines
N Saxena et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
C Cadwell et al.
GENE (2001)
Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gαi
MH Wyckoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Perspective: Nonreproductive sites of action of reproductive hormones
SC Manolagas et al.
ENDOCRINOLOGY (2001)
WISP-2: A serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells
MN Zoubine et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
T Simoncini et al.
NATURE (2000)
WISP-2 as a novel estrogen-responsive gene in human breast cancer cells
H Inadera et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Genetic heterogeneity in ductal carcinoma of the breast
JH Lichy et al.
LABORATORY INVESTIGATION (2000)
Share Paper
